Leqembi is the first Alzheimer’s antibody treatment to receive full FDA approval.
You are here: Home / Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer’s drug
Market News and Views
Leqembi is the first Alzheimer’s antibody treatment to receive full FDA approval.